ALT – altimmune, inc. (US:NASDAQ)
Stock Stats
News
Altimmune Announces that Pemvidutide Achieved Key Measures of Success at 48 Weeks in IMPACT Phase 2b MASH Trial [Yahoo! Finance]
Altimmune Announces that Pemvidutide Achieved Key Measures of Success at 48 Weeks in IMPACT Phase 2b MASH Trial
Altimmune announces CEO transition [Seeking Alpha]
Altimmune Announces CEO Transition and Succession Plan
Altimmune to Participate in the Piper Sandler 37th Annual Healthcare Conference [Yahoo! Finance]
Form 4 Altimmune, Inc. For: Dec 23 Filed by: GILL JOHN
Form 4 Altimmune, Inc. For: Dec 22 Filed by: Durso Jerome Benedict
Form 8-K Altimmune, Inc. For: Dec 19
Form EFFECT Altimmune, Inc.
Form 4 Altimmune, Inc. For: Dec 01 Filed by: Durso Jerome Benedict
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.